Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma

Clinical trial NCT04368078 · UNKNOWN

Trial details

NCT number: NCT04368078
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2020-07-11
Primary completion: 2024-04-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.